Nov 17, 2022, at 10:39 pm
New Delhi/Hyderabad: The government has denied allegations of irregularities in giving approvals to Bharat Biotech for manufacturing Covaxin, India's first indigenously developed vaccine for Covid-19.
Covaxin maker's nasal Covid vaccine cleared for emergency use, announces Mansukh Mandaviya
Sep 06, 2022, at 10:29 pm
New Delhi: Bharat Biotech’s needle-free intranasal vaccine against Covid-19 has gained emergency use approval in India Union health minister Mansukh Mandaviya confirmed on Tuesday.
India reports 3,303 new Covid-19 cases in 24 hours
Apr 28, 2022, at 04:30 pm
New Delhi/IBNS: India reported 3,303 new Covid-19 cases while the toll went up by 39 in the last 24 hours, the Union Health Ministry said on Thursday.
COVID-19: Covaxin, Corbevax get nod for 5-12 years
Apr 26, 2022, at 10:06 pm
New Delhi: Bharat Biotech's Covaxin has been approved for being administered to children between 6 and 12 years of age and Corbevax for children 5 to 12 years old, Union Health Minister Mansukh Mandaviya said on Wednesday.
COVID-19: Covishield and Covaxin prices slashed to Rs 225 per dose for Pvt centres
Apr 09, 2022, at 10:57 pm
New Delhi: A day before the rollout of precaution doses for the population aged between 18 and 59 years, the Covid-19 vaccine manufacturers have slashed the price of jabs by more than half.
Covid19: WHO suspends UN supply for Bharat Biotech's Covaxin
Apr 03, 2022, at 07:45 pm
Geneva: The World Health Organisation (WHO) has suspended the supply of Covaxin made by Indian manufacturer Bharat Biotech to upgrade facilities and address deficiencies revealed in an inspection, media reports said.
Covishield and Covaxin get DCGI's conditional approval for sale in regular market
Jan 27, 2022, at 10:22 pm
New Delhi/IBNS: Covishield and Covaxin have been granted approval by drugs regulator Drugs Control Regulator General of India (DCGI) for sale in the regular market.
In a big boost, Covaxin, Covishield get full market authorisation
Jan 20, 2022, at 06:12 am
New Delhi/IBNS: In a big boost to India's fight against COVID-19, an expert panel of the central drug authority on Wednesday cleared the country's two indigenous vaccines-Covaxin and Covishield-for full use.
Over 40 lakhs jabbed in age group 15-18 years on day 1 amid Covid third wave
Jan 04, 2022, at 04:02 am
New Delhi/IBNS: Amid a sharp rise in the COVID-19 cases feared to be the third wave and the Omicron infections' surge, India vaccinated over 40 lakhs teens in the 15 to 18 age group on Monday, Union Health Minister Mansukh Mandaviya said.
Over 3 lakh children registered on day 1 of COVID vaccination
Jan 02, 2022, at 02:11 pm
New Delhi/UNI: More than 3 lakh children enrolled for Covid vaccination as the Co-WIN portal opened for registration on Saturday for children between 15-18.
DCGI approves Covaxin shots for children above 12
Dec 26, 2021, at 04:38 am
Hyderabad/IBNS: Bharat Biotech's COVID-19 vaccine Covaxin received emergency approval from Drugs Controller General of India's (DCGI) for children between the ages of 12 and 18.
India's Bharat Biotech commences Covaxin exports
Nov 30, 2021, at 01:44 am
Hyderabad/UNI: Bharat Biotech International Limited on Monday announced it has commenced export of its Covid vaccine-Covaxin.
Two doses of India's COVAXIN is 50 percent effective against symptomatic COVID-19: Study
Nov 24, 2021, at 03:23 pm
New Delhi: The first real-world assessment of BBV152, a COVID-19 vaccine developed in India, known as COVAXIN in the country, suggests that two vaccine doses result in 50 percent effectiveness against symptomatic COVID-19.
Covaxin 77.8 pct effective against COVID-19: Lancet study
Nov 12, 2021, at 01:43 pm
London: Interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India and known as Covaxin, reports that two doses offer 77.8% protection against symptomatic COVID-19, finds Lancet study.
Hong Kong approves persons vaccinated with Covaxin for inbound travel
Nov 11, 2021, at 01:05 am
New Delhi/UNI: Travellers who have received both doses of Covaxin are now eligible for inbound travel to Hong Kong as the country has included the India-made COVID-19 vaccine into its list of approved vaccines.
UK to recognise India's Covaxin, no quarantine required for fully vaccinated travellers
Nov 09, 2021, at 06:04 am
London/IBNS: Britain on Monday said it would give approval to India's indigenous COVID-19 vaccine-Covaxin-and travellers inoculated with both the shots will not be required to quarantine, media reports said.
Bharat Biotech's US partner files request for paediatric use of Covaxin
Nov 07, 2021, at 02:03 am
New Delhi/UNI: Ocugen Inc, Bharat Biotech's partner in the US and Canada for Covaxin, has submitted a request to the US Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the Covid-19 jab for paediatric use.
Chinese vax took longer than COVAXIN to get approval, says WHO
Nov 04, 2021, at 06:20 am
New Delhi/IBNS: Covaxin did not take the longest to get the World Health Organization's (WHO) approval for Emergency Use Listing, according to Chief Scientist Dr Soumya Swaminathan.
Bharat Biotech's COVAXIN gets WHO approval
Nov 03, 2021, at 11:42 pm
New Delhi/IBNS: The World Health Organization (WHO) has given emergency use approval to Bharat Biotech's Covaxin, sources said Wednesday, clearing the way for the 'made-in-India' vaccine to get recognised by other nations and Indians inoculated with the shot would no longer need to self-quarantine or face restrictions when going abroad.
Oman approves India's Covaxin for travel without need for quarantine
Oct 28, 2021, at 05:09 am
Muscat/IBNS: The Government of the Sultanate of Oman on Wednesday approved Indian-made Covaxin to the list of allowed COVID-19 vaccines for travel to the country without quarantine.
Covaxin: WHO seeks 'additional clarifications', no emergency use nod given so far
Oct 27, 2021, at 02:14 pm
New Delhi/UNI: The process to include indigenously developed COVID-19 vaccine, Covaxin, in Emergency Use Listing (EUL) of World Health Organisation (WHO) is delayed by a week as the Technical Advisory Group of the UN body has sought "additional clarifications" from the vaccine manufacturer.
Bharat Biotech's Covaxin recommended for use in children below 18 years
Oct 13, 2021, at 03:23 am
New Delhi/IBNS: An expert panel on Tuesday recommended Bharat Biotech's Covaxin to be administered on children between the ages of two and 18.
Decision on Covaxin's clearance next: WHO
Oct 06, 2021, at 04:20 am
New Delhi/IBNS: The World Health Organisation (WHO) on Tuesday said it will announce its decision on clearance of India's indigenously developed Covaxin next week when the UN agency and an independent group of experts meet.
WHO's clearance to Bharat Biotech's Covaxin delayed: Reports
Sep 28, 2021, at 03:12 am
New Delhi/IBNS: The World Health Organization (WHO) has further delayed the emergency use authorisation (EUA) for Covaxin, the COVID vaccine developed in India by pharmaceutical company Bharat Biotech, media reports said.
India won't buy 'expensive' Moderna, Pfizer Covid-19 shots as local production soars: Report
Sep 22, 2021, at 03:40 am
New Delhi/IBNS: India would not buy Covid-19 vaccines from foreign producers Pfizer/BioNTech and Moderna as domestic production of the shots has increased manifold, Reuters reported citing sources.
WHO approval for Covaxin likely by month-end, says Niti Aayog
Sep 14, 2021, at 10:06 pm
New Delhi/IBNS: The World Health Organisation's emergency approval for indigenously made Covid-19 jab, Covaxin, can come by the end of September, said Dr VK Paul, chairman of the National Expert Committee on Vaccine Administration, according to media reports.
COVID-19: India reports 25,404 new infections, 339 deaths in 24 hours
Sep 14, 2021, at 04:10 pm
New Delhi/UNI/IBNS: India logged 25,404 new cases and 339 deaths due to the COVID-19 in the last 24 hours, the Union Health Ministry said Tuesday.
Health Minister Mansukh Mandaviya meets WHO chief scientist to discuss Covaxin approval
Aug 13, 2021, at 05:47 am
New Delhi/IBNS: Union Health Minister Mansukh Mandaviya on Thursday met World Health Organisation (WHO) Chief Scientist Dr Soumya Swaminathan to hold discussion over the global health body's approval for Bharat Biotech's COVID-19 vaccine Covaxin.
Study on mixing Covaxin, Covishield gets drug controller's approval
Aug 11, 2021, at 08:46 pm
New Delhi/IBNS: The Drugs Controller General Of India (DCGI) has given its nod to a study on mixing Covishield and Covaxin, the two main vaccines used in India's COVID-19 vaccination programme.
India reports 35,499 new COVID-19 cases in 24 hours
Aug 09, 2021, at 04:17 pm
New Delhi/IBNS: India added 35,499 new COVID-19 cases Monday while the toll went up by 447 in the last 24 hours.